Brain's immune system triggers frontotemporal dementia

by Nicholas Weiler,University of California, San FranciscoFrontotemporal dementia (FTD), the second most common cause of dementia in people under 65, may be triggered by a defect in immune cells

Updated on: February 28,2024

Brain's immune system triggers frontotemporal dementia

by Nicholas Weiler,University of California, San FranciscoFrontotemporal dementia (FTD), the second most common cause of dementia in people under 65, may be triggered by a defect in immune cells

Updated on:February 28,2024

Diabetes drug shows promise for safely treating, detecting Alzheimer's disease

by Boston University Medical CenterAs the number of patients with Alzheimer's disease (AD) rapidly increases, new treatments as well as blood tests that are simple and can be easily performed

Updated on: March 07,2024

Diabetes drug shows promise for safely treating, detecting Alzheimer's disease

by Boston University Medical CenterAs the number of patients with Alzheimer's disease (AD) rapidly increases, new treatments as well as blood tests that are simple and can be easily performed

Updated on:March 07,2024

Increase in registration of dementia as a cause of death

by IOS PressCredit: CC0 Public DomainIt is well known that dementia is associated with increased mortality. New scientific research shows how in recent years more deaths are being registered with

Updated on: June 24,2024

Increase in registration of dementia as a cause of death

by IOS PressCredit: CC0 Public DomainIt is well known that dementia is associated with increased mortality. New scientific research shows how in recent years more deaths are being registered with

Updated on:June 24,2024

FDA defends approval of controversial Alzheimer's drug

by Dennis ThompsonThe U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defendi

Updated on: March 30,2024

FDA defends approval of controversial Alzheimer's drug

by Dennis ThompsonThe U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defendi

Updated on:March 30,2024

Virtual reality app offers unique glimpse into life with dementia

by Alzheimer's Research UKCredit: Alzheimer's Research UKAn innovative virtual reality smartphone app – "A Walk Through Dementia" – will launch at a three-day public installatio

Updated on: March 09,2024

Virtual reality app offers unique glimpse into life with dementia

by Alzheimer's Research UKCredit: Alzheimer's Research UKAn innovative virtual reality smartphone app – "A Walk Through Dementia" – will launch at a three-day public installatio

Updated on:March 09,2024

Extending use of existing Alzheimer's drug could delay move into nursing home

by Alzheimer's Research UKDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Newly-released follow-up analysis from a 2012 clinical trial led by a

Updated on: February 26,2024

Extending use of existing Alzheimer's drug could delay move into nursing home

by Alzheimer's Research UKDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Newly-released follow-up analysis from a 2012 clinical trial led by a

Updated on:February 26,2024

Unique immune signatures can distinguish rare autoimmune condition from multiple sclerosis

Updated on: December 12,2025

Unique immune signatures can distinguish rare autoimmune condition from multiple sclerosis

Updated on:December 12,2025

Researchers develop combined data model to better evaluate for mild cognitive impairment

by Boston University School of MedicineA new study has shown that by combining imaging and neuropsychological testing, one can more accurately assess the cognitive status of individuals.Cognitive

Updated on: March 07,2024

Researchers develop combined data model to better evaluate for mild cognitive impairment

by Boston University School of MedicineA new study has shown that by combining imaging and neuropsychological testing, one can more accurately assess the cognitive status of individuals.Cognitive

Updated on:March 07,2024

The cloud facilitates independent living for the elderly

by CORDISCredit: Maria Fernanda Cabrera UmpiérrezAging can be accompanied by cognitive deterioration that may affect life quality and possibly safety. EU research has developed a range of ICT sol

Updated on: March 09,2024

The cloud facilitates independent living for the elderly

by CORDISCredit: Maria Fernanda Cabrera UmpiérrezAging can be accompanied by cognitive deterioration that may affect life quality and possibly safety. EU research has developed a range of ICT sol

Updated on:March 09,2024

Alzheimer's disease: have we got the cause all wrong?

by Vicky Jones,The ConversationCredit: Unsplash/CC0 Public DomainEarly in the 20th century,Alois Alzheimerfirst described a disorder of progressive memory loss and confusion in a 50-

Updated on: April 10,2024

Alzheimer's disease: have we got the cause all wrong?

by Vicky Jones,The ConversationCredit: Unsplash/CC0 Public DomainEarly in the 20th century,Alois Alzheimerfirst described a disorder of progressive memory loss and confusion in a 50-

Updated on:April 10,2024

An anti-apoE4 specific monoclonal antibody counteracts the pathological effects of apoE4 in vivo

by Bentham Science PublishersThe pathological hallmarks of Alzheimer's disease (AD), viz defective Aβ and tau proteins, have been the center of AD-directed therapeutic studies. Although this appro

Updated on: March 07,2024

An anti-apoE4 specific monoclonal antibody counteracts the pathological effects of apoE4 in vivo

by Bentham Science PublishersThe pathological hallmarks of Alzheimer's disease (AD), viz defective Aβ and tau proteins, have been the center of AD-directed therapeutic studies. Although this appro

Updated on:March 07,2024

'Lesser of two evils' argument used to defend antipsychotic overuse for dementia

by University of ReadingCredit: University of ReadingThe increasing use of antipsychotic drugs to manage dementia in care homes has been explained by some practitioners as "the lesser of two

Updated on: March 09,2024

'Lesser of two evils' argument used to defend antipsychotic overuse for dementia

by University of ReadingCredit: University of ReadingThe increasing use of antipsychotic drugs to manage dementia in care homes has been explained by some practitioners as "the lesser of two

Updated on:March 09,2024